Biotech Investors Zero In on Gene Therapy as Next Big Frontier
Research specialists work on gene editing. (Photographer: Bradley C. Bower/Bloomberg)

Biotech Investors Zero In on Gene Therapy as Next Big Frontier

(Bloomberg) -- Biotech investors are bullish on the market for gene therapies, even though actual sales of a few existing drugs have so far failed to impress some Wall Street analysts.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.